Hu et al. examined Nrf2 sequences of 103 patients with NSCLC and discovered that the Nrf2 mutation rate in ever-smokers was significantly higher than that in never-smokers [30]. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.